Great Point Partners’s Ambit Biosciences Corp AMBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-600,000
Closed -$9.24M 45
2014
Q3
$9.24M Sell
600,000
-453,895
-43% -$3.12M 3.97% 9
2014
Q2
$7.28M Buy
1,053,895
+334,634
+47% +$2.35M 3.24% 14
2014
Q1
$6.56M Sell
719,261
-13,339
-2% -$142K 3.43% 10
2013
Q4
$7.06M Sell
732,600
-150,859
-17% -$2.01M 4.99% 5
2013
Q3
$13.7M Buy
+883,459
New +$11.7M 9.5% 3

Great Point Partners's AMBI Position: Q4 2014 in Review

Great Point Partners sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 600,000 shares — an estimated $9.24M sold.

Great Point Partners first reported a position in AMBI in Q3 2013 and held it in 5 quarters. The position peaked at $13.7M in Q3 2013. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

  • Great Point Partners reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
  • Great Point Partners sold 600,000 Ambit Biosciences Corp shares in Q4 2014, an estimated $9.24M.
  • Great Point Partners first reported a position in Ambit Biosciences Corp in Q3 2013 and held it in 5 quarters.
  • Great Point Partners's Ambit Biosciences Corp position peaked at $13.7M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on Great Point Partners's 13F filing for Q4 2014, filed 17 Feb 2015.